Managing Director at Ehrlich & Fenster, of Ehrlich Group
Gal Ehrlich is the founder and managing director of Ehrlich Group, a firm which specialises in the IP field. Dr Ehrlich has a BSc in biology and a PhD in genetic engineering from the Hebrew University of Jerusalem. He also has an LLB from Tel Aviv University Law School.
Since 1994, Dr Ehrlich has been involved in preparing and prosecuting patent applications in all high-tech fields, including biotechnology, agrotechnology, medicine, pharmaceuticals, computers, communications, physics, chemistry and medical devices.
In 2000 Dr Ehrlich founded Ehrlich & Partners. In 2006 the firm merged with Fenster & Co to become Ehrlich & Fenster, which employs 150 individuals and has become Israel’s leading patent attorney firm. In 2017 Dr Ehrlich formed the Ehrlich Group, which serves thousands of clients, including Israel’s leading universities and academic institutions and many well-known major companies, start-ups and private clients.
Ehrlich & Fenster has been recognised as a leading patent attorney firm in Israel and has been ranked as a Tier 1 firm for four consecutive years by Managing Intellectual Property’s World IP Survey and the IAM Patent 1000. The group is ranked Tier 1 for both patent prosecution and trademark and copyright prosecution in the Legal 500 2019.
Dr Ehrlich has also been ranked individually as a Tier 1 professional.